REGISTERED NUMBER: SC651640 (Scotland)

Unaudited Financial Statements for the Year Ended 31 August 2025

for

Apothicare Pharma Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

R Mackie

Mrs G Mackie

Mrs E Brice

P Slowey

SECRETARY:

R Mackie

REGISTERED OFFICE:

26 Douglas Avenue

Airth Castle

Airth

FK2 8GF

REGISTERED NUMBER:

SC651640 (Scotland)

ACCOUNTANTS:

Clements

Chartered Accountants

39 St Vincent Place

Glasgow

G1 2ER

FIXED ASSETS

Investments

4

678,175

678,175

CURRENT ASSETS

Cash at bank

34

189

CREDITORS

Amounts falling due within one year

5

338,723

389,403

NET CURRENT LIABILITIES

(338,689

)

(389,214

)

TOTAL ASSETS LESS CURRENT LIABILITIES

339,486

288,961

CREDITORS

Amounts falling due after more than one year

6

113,468

137,813

NET ASSETS

226,018

151,148

CAPITAL AND RESERVES

Called up share capital

80,000

80,000

Retained earnings

146,018

71,148

SHAREHOLDERS' FUNDS

226,018

151,148

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 April 2026 and were signed on its behalf by:

R Mackie - Director

1.	STATUTORY INFORMATION

Apothicare Pharma Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Investments in subsidiaries

Investments in subsidiary undertakings are recognised at cost.

Financial instruments

The company only has basic financial assets and liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Taxation

Taxation for the year comprises current and deferred tax.

The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax is recognised on all timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

4.	FIXED ASSET INVESTMENTS

Shares in

group

undertakings

£

COST

At 1 September 2024

and 31 August 2025

678,175

NET BOOK VALUE

At 31 August 2025

678,175

At 31 August 2024

678,175

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Parkchem Ltd

Registered office: 2, Harley Terrace, Sherburn, County Durham, DH6 1DS.

Nature of business: Pharmacy

%

Class of shares:

holding

Ordinary £1 shares

100.00

31.8.25

31.8.24

£

£

Aggregate capital and reserves

84,851

140,098

Profit for the year

45,337

49,691

5.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.8.25

31.8.24

£

£

Bank loans and overdrafts

24,345

24,323

Amounts owed to group undertakings

-

48,734

Other creditors

314,378

316,346

338,723

389,403

Included in other creditors is a loan of £295,000 from Mallaig Village Pharmacy Ltd, a company whose share capital is wholly owned by directors Mr & Mrs Mackie.

6.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.8.25

31.8.24

£

£

Bank loans

113,468

137,813

7.	SECURED DEBTS

The following secured debts are included within creditors:

31.8.25

31.8.24

£

£

Bank loans

137,813

162,136

The Bank of Scotland hold a floating change over all the property or undertaking of the company.

8.	RELATED PARTY DISCLOSURES

Eilidh Brice, Dividends paid C Ord Shares £2,500. (2024 - £Nil).

Peter Slowey, Dividends paid D Ord Shares £2,500. (2024 - £Nil).